Jerusalem Pharmaceuticals
- Company typePrivate
- Founded1975
- HeadquartersRamallah
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Jerusalem Pharmaceuticals firmographics
Firmographics- Name
- Jerusalem Pharmaceuticals
- Legal name
- Jerusalem Pharmaceuticals Co.
- Website
- https://jepharm.ps
- Company type
- Private
- Founded year
- 1975
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Jerusalem Pharmaceuticals industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industries
- Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)
Keywords
Where Jerusalem Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Ramallah
Offices3 records
Markets served
Jerusalem Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Generic Pharmaceutical Products: Develops, manufactures and markets generic medicines as well as veterinary and agricultural products in the Middle East and North Africa
- Veterinary and Agricultural Products: Fifth facility manufactures veterinary and agricultural products at a dedicated manufacturing site
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Jerusalem Pharmaceuticals product offering
Product offeringCore offering
Jerusalem Pharmaceuticals Co. develops, manufactures, and markets generic pharmaceutical products for human use, complemented by veterinary, agricultural, and personal/home care products. Production is carried out across more than four manufacturing facilities in Palestine, Jordan, and Algeria, serving healthcare providers and patients across the MENA region. The portfolio is organized into three business units: Pharmaceutical Products, Veterinary & Agricultural Products, and Personal & Home Care Products.
Product overview
Jerusalem Pharmaceuticals operates as a public listed pharmaceutical company with a diversified portfolio organized into three main business units: (1) Pharmaceutical Products encompassing the Jerusalem Pharmaceuticals Company, Jordan River Pharmaceuticals Company, and S.A. Soprodim Factory, all focused on developing, manufacturing, and marketing generic medicinal products across the MENA region; (2) Veterinary and Agricultural Products produced at a dedicated manufacturing facility; and (3) Personal & Home Care Products. The company operates 4 pharmaceutical manufacturing facilities located in Palestine, Jordan, and Algeria, with a fifth dedicated facility for veterinary and agricultural products.
Differentiator
Problem solved
Functional benefit
Brands
- Jerusalem Pharmaceuticals Company: Core pharmaceutical products manufacturing and marketing business unit.
- Jordan River Pharmaceuticals Company
- S.A. Soprodim Factory
- Jerusalem Veterinary Agricultural Products Company
Products and services
- Pharmaceutical Products (Human)
- Veterinary and Agricultural Products
- Personal & Home Care Products
Companies that use Jerusalem Pharmaceuticals
Customer profileSegments1 record
Ideal customer profiles1 record
Jerusalem Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Jerusalem Pharmaceuticals partnerships and signals
Strategic signalScale indicators4 records
Recent moves3 records
Expansion highlights4 records
Jerusalem Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Tabuk Pharmaceuticals: Saudi-based generic and specialty pharma company with MENA-wide distribution; comparable in regional manufacturing and generics focus.
- Eva Pharma: Egypt-based pharmaceutical manufacturer with a generics-led portfolio and expanding MENA presence; comparable in product breadth and regional GTM.
- EIPICO (Egyptian International Pharmaceutical Industries): One of the largest generic pharmaceutical manufacturers in Egypt and MENA; comparable in scale of generic manufacturing and breadth of therapeutic coverage.
- Pharma International: Jordan-based generic pharmaceutical manufacturer with regional MENA distribution; comparable in scale, product mix, and geographic focus.
- Hikma Pharmaceuticals: Jordan-headquartered generic and specialty pharmaceutical manufacturer with deep MENA and US presence; the closest large-scale direct peer in terms of generic pharma manufacturing and regional distribution.
- Julphar (Gulf Pharmaceutical Industries): UAE-based generic and specialty pharma manufacturer serving MENA markets; comparable in MENA-centric manufacturing footprint and generic product portfolio.
- SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Saudi listed generic pharmaceutical manufacturer with MENA distribution; comparable as a regional generic peer serving government health systems and tenders.
- Dar Al Dawa: Jordan-based generic pharmaceutical manufacturer with multi-country operations across MENA; comparable in product mix (generics) and regional go-to-market.
Broad incumbents
- Cipla: Indian-headquartered global generic manufacturer with significant MENA presence; comparable as a generics-led manufacturer that competes in MENA tenders with Jerusalem Pharma.
Emerging players
- MS Pharma: Jordan-headquartered specialty and generic pharmaceutical company with MENA operations; comparable as a regional generic and specialty manufacturer.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Jerusalem Pharmaceuticals compliance and trust
Trust signalCompliance1 record
Jerusalem Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jerusalem Pharmaceuticals leadership team
Management profileNumber of profiles
Jerusalem Pharmaceuticals subsidiaries and ownership
Company hierarchySubsidiaries4 records
Jerusalem Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jerusalem Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jerusalem Pharmaceuticals
What does Jerusalem Pharmaceuticals do?
Jerusalem Pharmaceuticals Co. develops, manufactures, and markets generic pharmaceutical products for human use, complemented by veterinary, agricultural, and personal/home care products. Production is carried out across more than four manufacturing facilities in Palestine, Jordan, and Algeria, serving healthcare providers and patients across the MENA region. The portfolio is organized into three business units: Pharmaceutical Products, Veterinary & Agricultural Products, and Personal & Home Care Products.
When was Jerusalem Pharmaceuticals founded?
Jerusalem Pharmaceuticals was founded in 1975. It employs 251 to 500 people.
Where is Jerusalem Pharmaceuticals based?
Jerusalem Pharmaceuticals is headquartered in Ramallah.
How does Jerusalem Pharmaceuticals make money?
Two revenue lines are on record. Generic Pharmaceutical Products are the primary driver. The others are veterinary and Agricultural Products.
Who are Jerusalem Pharmaceuticals's main competitors?
Direct peers on record are Tabuk Pharmaceuticals, Eva Pharma, EIPICO (Egyptian International Pharmaceutical Industries), Pharma International, Hikma Pharmaceuticals, Julphar (Gulf Pharmaceutical Industries), SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation) and Dar Al Dawa. Cipla is listed as a broad incumbent. MS Pharma is listed as an emerging player.
Does Jerusalem Pharmaceuticals have an API?
No public API is recorded for Jerusalem Pharmaceuticals.
What industry is Jerusalem Pharmaceuticals in?
Jerusalem Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAMAIAC, Veterinary Vaccine & Biologics Distributors. Its NAICS code is 325412 and its SIC code is 2834.